Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ROCKET PHARMACEUTICALS, INC.

(RCKT)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Upcoming events on ROCKET PHARMACEUTICALS, INC.
08/11/21 
11/10/21 
03/10/22 
05/11/22 
Past events on ROCKET PHARMACEUTICALS, INC.
06/14/21 
05/26/21 
05/13/21 | 10:00am 
05/13/21 
Upcoming sector events for ROCKET PHARMACEUTICALS, INC.
06/22/21 BIONTECH SE : Annual General Meeting
06/22/21 | 08:00am REGENERON PHARMACEUTICALS : BMO Biopharma Day
07/28/21 GILEAD SCIENCES, INC. : Interim 2021 Earnings Release (Projected)
07/28/21 VERTEX PHARMACEUTICALS : Interim 2021 Earnings Release (Projected)
More events
Past sector events for ROCKET PHARMACEUTICALS, INC.
06/11/21 | 10:30am REGENERON PHARMACEUTICALS : Annual General Meeting
06/11/21 | 03:00am VERTEX PHARMACEUTICALS : European Hematology Association Congress - Abstract #EP733
06/11/21 | 03:00am VERTEX PHARMACEUTICALS : European Hematology Association Congress - Abstract #EP736
06/10/21 | 04:30pm VERTEX PHARMACEUTICALS INCORPORATED : VX-864 Phase 2 Study Results Call
Annual publications
Annual results20172018201920202021 (e)
Sales
M $
Released
Forecast
Spread









10,0
Operating income
(EBITDA)
M $
Released
Forecast
Spread


-70,8
-63,0
-12%
-76,1
-91,0
16%
-133
-102
-31%

-155
Operating profit
(EBIT)
M $
Released
Forecast
Spread
-26,7
-31,0
14%
-71,2
-62,1
-15%
-76,2
-82,7
7,9%
-134
-104
-29%

-157
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread


-74,5
-65,2
-14%
-77,3
-84,7
8,8%
-140
-110
-28%

-163
Net income
M $
Released
Forecast
Spread


-74,5
-65,2
-14%
-77,3
-84,1
8,1%
-140
-109
-28%

-162
EPS
$
Released
Forecast
Spread


-1,89
-1,66
-14%
-1,58
-1,68
5,7%
-2,52
-1,93
-30%

-2,60
Announcement Date03/07/201803/07/201903/05/202002/25/2021

Quarterly publications
Previous periodNext period
Quarterly results2020 Q12020 Q22020 Q32020 Q42021 Q12021 Q2 (e)
Sales
M $
Released
Forecast
Spread












Operating income
(EBITDA)
M $
Released
Forecast
Spread
-24,0
-43,0
44%
-23,4
-33,0
29%
-27,1
-25,0
-8,5%
-58,6
-26,3
-122%
-38,5
-31,9
-21%

-36,5
Operating profit
(EBIT)
M $
Released
Forecast
Spread
-24,1
-24,1
-0,08%
-23,6
-29,2
19%
-27,4
-25,4
-8,0%
-59,2
-29,1
-104%
-39,2
-40,3
2,6%

-40,3
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
-24,7
-24,7
0,15%
-25,0
-32,5
23%
-29,1
-26,8
-8,7%
-60,9
-30,7
-98%
-40,2
-44,7
10%

-42,8
Net income
M $
Released
Forecast
Spread
-24,7
-24,7
0,00%
-25,0
-30,1
17%
-29,1
-26,3
-11%
-60,9
-30,4
-100%
-40,2
-42,8
6,1%

-41,5
EPS
$
Released
Forecast
Spread
-0,45
-0,43
-3,8%
-0,45
-0,51
11%
-0,53
-0,47
-14%
-1,08
-0,51
-110%
-0,65
-0,71
7,8%

-0,66
Announcement Date05/08/202008/05/202011/04/202002/25/202105/10/2021

Financial data source
© 2021 S&P Global Market Intelligence
© 2021 Factset
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise